The global automated nucleic acid extraction market size was valued at US$ 3.6 Bn in 2025 and is projected to reach US$ 11.7 ...
Thermo Fisher Scientific Launches Invitrogen™ TaqMan™ Cells-to-CT™ HepatoExpress Kit to Simplify Liver Cell Gene Expression and Help Advance Early-Stage Drug ...
News-Medical.Net on MSN
MolGen continues its activities as AgriGenX
The transition to AgriGenX ensures full continuity for existing customers and partners. The current portfolio of products, ...
Understanding how a potential drug is metabolised in the liver is a critical first step in early-stage drug development - but ...
A giant impact on the early Earth could have brought the building blocks of RNA to our planet, which new research suggests ...
Nucleosomes are barriers to RNA Polymerase II (Pol II) transcribing along gene bodies in eukaryotes. We found that a fragile “tailless nucleosome” could be generated to resolve the Pol II pausing ...
Validated clinical efficacy and scalable manufacturing propel exosomes from research discovery to commercial therapeutics.
The rise of antibiotic resistance has renewed interest in bacteriophages as therapeutic alternatives. However, co-evolution of phage and bacteria will naturally give rise to phage-resistant pathogens, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback